A comparative double blind placebo-controlled study of immunogenicity and safety of two doses 10exp5 and 10exp7 CFU of SC599 oral vaccine, a live attenuated Shigella dysenteriae 1 vaccine strain in healthy human adult volunteers
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Shigella dysenteriae vaccine (Primary)
- Indications Shigella infections
- Focus Pharmacodynamics
- 08 Aug 2018 Biomarkers information updated
- 16 Mar 2010 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
- 16 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.